TITLE

CNX-011-67, a novel GPR40 agonist, enhances glucose responsiveness, insulin secretion and islet insulin content in n-STZ rats and in islets from type 2 diabetic patients

AUTHOR(S)
Sunil, Venkategowda; Verma, Mahesh Kumar; Oommen, Anup M.; Sadasivuni, Manojkumar; Singh, Jaideep; Vijayraghav, Dasarahalli N.; Chandravanshi, Bhawna; Shetty, Jayalaxmi; Biswas, Sanghamitra; Dandu, Anilkumar; Moolemath, Yoganand; Venkataranganna, Marikunte V.; Somesh, Baggavalli P.; Jagannath, Madanahalli R.
PUB. DATE
March 2014
SOURCE
BMC Pharmacology & Toxicology;2014, Vol. 15 Issue 1, p19
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: GPR40 is a G-protein coupled receptor regulating free fatty acid induced and also glucose induced insulin secretion. We generated neonatally-streptozotocin-treated female rats (n-STZ) and treated them with CNX-011-67, a GPR40 agonist to examine the role of GPR40 in modulation of glucose metabolism, insulin secretion and content. Methods: Female n-STZ animals were orally administered with CNX-011-67 (15 mg/kg body weight, twice daily) or with vehicle for 8 weeks (n = 8 per group). Glucose tolerance in treated animals and insulin secretion, islet insulin content and gene expression in isolated islets were determined. Islets from type 2 diabetic mellitus (T2DM) patients were treated with different concentrations of glucose in presence or absence of CNX-011-67 and insulin secretion was measured. Results: Treatment of n-STZ rats with GPR40 agonist CNX-011-67 enhanced insulin secretion in response to oral glucose load on day 0 and this response persisted during the treatment period. The treatment also produced a ‘memory effect’ during which insulin secretion in response to oral glucose load remained enhanced, for a week, even in absence of the agonist. Activation of GPR40 enhanced responsiveness of islets to glucose and increased glucose induced insulin secretion and islet insulin content. An increase in islet mRNA expression of GCK, PDX1, insulin and PC was also observed. Acute treatment of islets from n-STZ rats with GPR40 agonist enhanced cellular ATP content. Activation of GPR40 enhanced mitochondrial calcium level in NIT-1 insulinoma cells. CNX-011-67 increased insulin secretion in islets from T2DM patients which were non-responsive to increased glucose concentration Conclusions: Our data provide evidence that activation of GPR40 with CNX-011-67 stimulates glucose metabolism, enhances glucose responsiveness, increases insulin secretion and content and that pharmacological activation of GPR40 will prove beneficial for treatment of T2DM.
ACCESSION #
110347064

 

Related Articles

  • Treatment with CNX-011-67, a novel GPR40 agonist, delays onset and progression of diabetes and improves beta cell preservation and function in male ZDF rats. Gowda, Nagesh; Dandu, Anil kumar; Singh, Jaideep; Biswas, Sanghamitra; Raghav, Vijaya; Lakshmi, Mudigere N.; Shilpa, Pavagada C.; Sunil, Venkategowda; Reddy, Ashok kumar; Sadasivuni, Manoj kumar; Aparna, Kumaraswamy; Verma, Mahesh Kumar; Moolemath, Yoganand; Anup, Mammen O.; Venkataranganna, Marikunte V.; Somesh, Baggavalli P.; Jagannath, Madanahalli R. // BMC Pharmacology & Toxicology;2013, Vol. 14 Issue 1, p1 

    Background: The role of G protein-coupled receptor (GPR40), which is highly expressed in pancreatic beta cells, has been studied extensively in the amelioration of beta cell dysfunction in T2D using rat and mouse islets, beta cell lines and in animal models of diabetes. But its potential as a...

  • Selective Small-Molecule Agonists of G Protein-Coupled Receptor 40 Promote Glucose-Dependent Insulin Secretion and Reduce Blood Glucose in Mice. Tan, Carina P.; Yue Feng; Yun-Ping Zhou; Eiermann, George J.; Petrov, Aleksandr; Zhou, Changyou; Lin, Songnian; Salituro, Gino; Meinke, Peter; Mosley, Ralph; Akiyama, Taro E.; Einstein, Monica; Kumar, Sanjeev; Berger, Joel P.; Mills, Sander G.; Thornberry, Nancy A.; Lihu Yang; Howard, Andrew D. // Diabetes;Aug2008, Vol. 57 Issue 8, p2211 

    OBJECTIVE--Acute activation of G protein-coupled receptor 40 (GPR40) by free fatty acids (FFAs) or synthetic GPR40 agonists enhances insulin secretion. However, it is still a matter of debate whether activation of GPR40 would be beneficial for the treatment of type 2 diabetes, since chronic...

  • Overexpression of GPR40 in Pancreatic β-Cells Augments Glucose-Stimulated Insulin Secretion and Improves Glucose Tolerance in Normal and Diabetic Mice. Nagasumi, Kae; Esaki, Ritsuko; Iwachidow, Kimihiko; Yasuhara, Yoshitaka; Ogi, Kazuhiro; Tanaka, Hideyuki; Nakata, Mitsugu; Yano, Takashi; Shimakawa, Kozo; Taketomi, Shigehisa; Takeuchi, Koji; Odaka, Hiroyuki; Kaisho, Yoshihiko // Diabetes;May2009, Vol. 58 Issue 5, p1067 

    OBJECTIVE--GPR40 is a G protein-coupled receptor regulating free fatty acid-induced insulin secretion. We generated transgenic mice overexpressing the hGPR40 gene under control of the mouse insulin II promoter and used them to examine the role of GPR40 in the regulation of insulin secretion and...

  • Activation of GPR40 attenuates chronic inflammation induced impact on pancreatic β-cells health and function. Kumar Verma, Mahesh; Kumar Sadasivuni, Manoj; Yateesh, Aggunda N.; Neelima, Korrapati; Mrudula, Srikanth; Reddy, Madhusudhan; Smitha, Rachapalli; Biswas, Sanghamitra; Chandravanshi, Bhawna; Pallavi, Puttrevana M.; Oommen, Anup M.; Jagannath, Madanahalli R.; Somesh, Baggavalli B. // BMC Cell Biology;2014, Vol. 15 Issue 1, p1 

    Background Chronic inflammation-mediated β-cell apoptosis is known to decrease β-cell mass in diabetes leading to reduced insulin secretion. Exposure to pro-inflammatory cytokines can stimulate apoptosis in pancreatic β-cells. The G protein coupled receptor 40 (GPR40) is implicated for...

  • A Potent Class of GPR40 Full Agonists Engages the EnteroInsular Axis to Promote Glucose Control in Rodents. Jian Luo; Swaminath, Gayathri; Brown, Sean P.; Zhang, Jane; Qi Guo; Chen, Michael; Nguyen, Kathy; Tran, Thanhvien; Miao, Lynn; Dransfield, Paul J.; Vimolratana, Marc; Houze, Jonathan B.; Wong, Simon; Toteva, Maria; Bei Shan; Li, Frank; Run Zhuang; Lin, Daniel C.-H. // PLoS ONE;Oct2012, Vol. 7 Issue 10, Special section p1 

    Type 2 diabetes is characterized by impaired glucose homeostasis due to defects in insulin secretion, insulin resistance and the incretin response. GPR40 (FFAR1 or FFA1) is a G-protein-coupled receptor (GPCR), primarily expressed in insulin-producing pancreatic b-cells and incretin-producing...

  • G protein-coupled receptor (GPR)40-dependent potentiation of insulin secretion in mouse islets is mediated by protein kinase D1. Ferdaoussi, M.; Bergeron, V.; Zarrouki, B.; Kolic, J.; Cantley, J.; Fielitz, J.; Olson, E.; Prentki, M.; Biden, T.; MacDonald, P.; Poitout, V. // Diabetologia;Oct2012, Vol. 55 Issue 10, p2682 

    Aims/hypothesis: Activation of the G protein-coupled receptor (GPR)40 by long-chain fatty acids potentiates glucose-stimulated insulin secretion (GSIS) from pancreatic beta cells, and GPR40 agonists are in clinical development for type 2 diabetes therapy. GPR40 couples to the G protein subunit...

  • Elevated vascular endothelial growth factor production in islets improves islet graft vascularization. Zhang, Nan; Richter, Anja; Suriawinata, Jenny; Harbaran, Sonal; Altomonte, Jennifer; Cong, Lin; Zhang, Haojiang; Song, Keying; Meseck, Marcia; Bromberg, Jonathan; Dong, Hengjiang // Diabetes;Apr2004, Vol. 53 Issue 4, p963 

    Successful islet transplantation depends on the infusion of sufficiently large quantities of islets, of which only approximately 30% become stably engrafted. Rapid and adequate revascularization of transplanted islets is important for islet survival and function. Delayed and insufficient...

  • Somatostatin Secreted by Islet δ-Cells Fulfills Multiple Roles as a Paracrine Regulator of Islet Function. Hauge-Evans, Astrid C.; King, Aileen J.; Carmignac, Danielle; Richardson, Carolyn C.; Robinson, Iain C .A .F.; Low, Malcolm J.; Christie, Michael R.; Persaud, Shanta J.; Jones, Peter M. // Diabetes;Feb2009, Vol. 58 Issue 2, p403 

    OBJECTIVE--Somatostatin (SST) is secreted by islet δ-cells and by extraislet neuroendocrine cells. SST receptors have been identified on α- and β-cells, and exogenous SST inhibits insulin and glucagon secretion, consistent with a role for SST in regulating α- and β-cell function....

  • Pancreatic Thyrotropin Releasing Hormone and Mechanism of Insulin Secretion. Štrbák, Vladimír // Cellular Physiology & Biochemistry (Karger AG);2018, Vol. 50 Issue 1, p378 

    Thyrotropin releasing hormone (TRH; pGlu-His-ProNH2) is expressed also in pancreatic β cells where it is colocalized in secretory granules with insulin. High perinatal changes of the TRH gene expression and TRH concentrations in rat pancreatic islets coincide with the perinatal maturation of...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics